Experience of the anti-inflammatory eye drops Ivinak®-SOLOpharm use in patients after cataract surgery
- 作者: Pirogov I.1,2,3,4, Rozhdestvenskiy F.1,2, Dzitstsoeva P.1,5, Artiushenko A.1,6
-
隶属关系:
- City Hospital No. 26
- Medical Center, Admiralteyskiye verfi Ltd.
- Saint Petersburg State University
- City Hospital No. 40, Polyclinic Department No. 68
- City Hospital No. 98
- 期: 卷 14, 编号 3 (2021)
- 页面: 71-76
- 栏目: Ophthalmopharmacology
- URL: https://journals.rcsi.science/ov/article/view/79196
- DOI: https://doi.org/10.17816/OV79196
- ID: 79196
如何引用文章
详细
BACKGROUND: The prevalence of inflammatory complications that occur after phacoemulsification remains an unsolved problem.
AIM: To analyze the results of the use of Ivinak®-SOLOpharm eye drops containing 0.09% bromfenac solution in the complex of anti-inflammatory therapy in patients after cataract surgery in comparison with similar drugs from other manufacturers.
MATERIALS AND METHODS: The study included 60 patients (60 eyes) with a diagnosis of “age-related cataract”, who underwent phacoemulsification. All patients were divided into 2 groups: in the first group, patients used Ivinac eye drops 3 days before surgery and 20 days after it; in the second group, patients used another similar drug containing 0.09% bromfenac solution according to an identical scheme. All patients underwent visual acuity testing and keratopachimetry before and after surgery. On Day 4 and Day 20 after surgery, the degree of inflammatory reaction of the eye was assessed by the number of cells in the anterior chamber fluid, subjective signs of inflammation in patients, using the OSDI (Ocular Surface Disease Index) questionnaire.
RESULTS: When analyzing the obtained data, no statistically significant differences were found between the groups in terms of best corrected visual acuity, corneal thickness, number of cells in the anterior chamber fluid, and subjective symptoms of inflammation in patients.
CONCLUSIONS: Ivinak®-SOLOpharm has proven its effectiveness and safety in the perioperative prevention of inflammatory processes in phacoemulsification.
作者简介
Iurii Pirogov
City Hospital No. 26; Medical Center, Admiralteyskiye verfi Ltd.; Saint Petersburg State University;
Email: visus1@yandex.ru
ORCID iD: 0000-0002-8791-5400
Head of the Ophthalmology Department, Associate Professor, Ophthalmologist
俄罗斯联邦, Saint Petersburg; Saint Petersburg; Saint PetersburgFedor Rozhdestvenskiy
City Hospital No. 26; Medical Center, Admiralteyskiye verfi Ltd.
Email: fedor_keyer@mail.ru
ophthalmologist
俄罗斯联邦, Saint Petersburg; Saint PetersburgPolina Dzitstsoeva
City Hospital No. 26; City Hospital No. 40, Polyclinic Department No. 68
Email: poli93@mail.ru
ophthalmologist
俄罗斯联邦, Saint Petersburg; Saint PetersburgAleksandra Artiushenko
City Hospital No. 26; City Hospital No. 98
编辑信件的主要联系方式.
Email: bovykina@gmail.com
ophthalmologist
俄罗斯联邦, Saint Petersburg; Saint Petersburg参考
- Takhtaev YuV. Intraokulyarnaya korrektsiya ametropii i presbiopii [dissertation]. Saint Petersburg, 2008. 37 p. (In Russ.)
- Astakhov YuS, Nikolaenko VP, editors. Oftal’mologiya. Farmakoterapiya bez oshibok. 2-nd edition: rukovodstvo dlya vrachei. Moscow: E-noto; 2021. 800 p. (Seriya “Farmakoterapiya bez oshibok”). (In Russ.)
- Pirogov YuI, Butina GV, Oksentyuk AA, Chshieva MR. The comparative analysis of treatment regimen for infectious complications prophylaxis at phacoemulsification. Kataraktal’naya i refraktsionnaya khirurgiya. 2011;11(3):52–53. (In Russ.).
- Aptel F, Colin C, Kaderli S, et al; OSIRIS group. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017;101:1451–1460. doi: 10.1136/bjophthalmol-2017-310324
- Spiridonov EA. Bromfenac (Broksinak) – a new word in the nonsteroidal antiinflamatory drug (literature review). Ophthalmology in Russia. 2015;12(4):18–26. (In Russ.) doi: 10.18008/1816-5095-2015-4-18-26
- Pirogov YuI, Nikolaenko VP. Vspomogatel’nye veshchestva glaznykh kapel’. Saint Petersburg: Eco-Vector; 2018. 54 p. (In Russ.)